>
Organization
Eisai Co., Ltd.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Eisai Co., Ltd.

... Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, 'Eisai') has announced that it received ...
... Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Merck (NYSE:MRK), known as ...
... Eisai Co., Ltd. (CEO: Haruo Naito; Headquarters: Tokyo, Japan, 'Eisai') and Eisai's subsidiary for ...
... Eisai Co., Ltd. announced today that its Chinese subsidiary, Eisai China Inc. (ECI) has ...
... antibody treatments for Alzheimer's disease from a research project jointly owned with Eisai BioArctic expanded the research collaboration with Uppsala University concerning antibody-based diagnostic imaging ...
... Leverenz is a consultant for Acadia Pharmaceuticals, Avid Radiopharmaceuticals, Axovant, Bracco Radiopharmaceuticals, Eisai, GE Healthcare and Takeda. Ted M. Dawson is a member of the ...
... in late-stage trials. The recent surprise announcement of disease-modifying effect obtained by Biogen/Eisai with their MAb BAN2401 in a Phase II trial may reignite interest ...
... Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, 'Eisai') announced that Eisai presented new ...
... Mass., Oct. 26, 2018 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: BIIB) and Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced that Biogen presented results ...
... Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, 'Eisai') today resolved to offer a ...
Subscribe now for full coverage on Eisai Co., Ltd.
Start My Free Trial